Retractable Technologies Profit Margin 2006-2018 | RVP

Current and historical gross margin, operating margin and net profit margin for Retractable Technologies (RVP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Retractable Technologies net profit margin as of September 30, 2018 is -6.72%.
Retractable Technologies Annual Profit Margins
Retractable Technologies Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.023B $0.034B
Retractable Technologies, Inc. designs, develops, manufactures, and markets innovative patented safety needle devices for the healthcare industry.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.940B 22.07
McKesson (MCK) United States $24.748B 9.45
Align Technology (ALGN) United States $17.604B 44.92
AmerisourceBergen (ABC) United States $16.925B 12.32
Cardinal Health (CAH) United States $14.614B 9.81
Laboratory Of America Holdings (LH) United States $13.894B 12.57
Cooper (COO) United States $13.274B 23.41
Henry Schein (HSIC) United States $12.088B 19.88
DENTSPLY SIRONA (XRAY) United States $9.087B 18.15
West Pharmaceutical Services (WST) United States $7.797B 38.69
Merit Medical Systems (MMSI) United States $2.939B 34.81
Patterson (PDCO) United States $2.117B 16.15
CONMED (CNMD) United States $1.874B 31.14
STAAR Surgical (STAA) United States $1.552B 159.82
Atrion (ATRI) United States $1.419B 40.56
Antares Pharma (ATRS) United States $0.484B 0.00
Lifevantage (LFVN) United States $0.205B 29.06
Invacare (IVC) United States $0.158B 0.00
Endologix (ELGX) United States $0.086B 0.00
Pro-Dex (PDEX) United States $0.057B 25.26
Aceto (ACET) United States $0.043B 0.00
Biolase (BIOL) United States $0.027B 0.00